Center for Interventional Pain Spine LLC

Center for Interventional Pain Spine LLC was paid $17.55M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 25% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	124,102	$151K
2019	254,797	$1.20M
2020	256,173	$4.18M
2021	220,213	$3.91M
2022	187,214	$3.39M
2023	236,116	$2.90M
2024incomplete	154,526	$1.82M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	25%	103,197	77,945	$4.39M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	15%	110,332	82,015	$2.72M
96138		7.4%	71,779	53,932	$1.29M
L0648	Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf	3.3%	2,485	1,996	$574K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.8%	34,270	30,418	$487K
96127		2.7%	156,330	99,662	$476K
92548		2.7%	8,424	7,172	$473K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	2.4%	6,599	5,407	$422K
62323		2.3%	4,348	3,225	$405K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.7%	12,773	5,478	$301K
80348		1.6%	29,411	26,939	$287K
80365		1.5%	32,377	29,499	$263K

100 more codes

80354		1.3%	29,399	$234K
98941	Chiropractic manipulative treatment; spinal, 3-4 regions	1.2%	14,332	$216K
98942		1.0%	8,402	$184K
98980		1.0%	5,938	$180K
64635		1.0%	1,211	$179K
80361		1.0%	32,405	$179K
80362		1.0%	29,421	$178K
80369		<1%	32,407	$175K
64493		<1%	3,561	$166K
80346		<1%	32,399	$164K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	23,581	$160K
62321		<1%	1,472	$158K
80375		<1%	29,391	$140K
98981		<1%	5,354	$138K
64483		<1%	1,675	$131K
80324		<1%	29,424	$130K
96160		<1%	103,222	$126K
80358		<1%	24,645	$124K
A4595	Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)	<1%	6,607	$117K
80321		<1%	32,414	$114K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	1,315	$110K
80349		<1%	29,415	$106K
27096		<1%	1,467	$103K
80373		<1%	32,399	$101K
80323		<1%	24,649	$98K
99386		<1%	891	$96K
20610		<1%	3,976	$95K
77002		<1%	3,980	$94K
64494		<1%	3,453	$92K
80356		<1%	29,335	$89K
80372		<1%	29,376	$89K
64636		<1%	1,166	$84K
80355		<1%	32,384	$78K
E0730	Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation	<1%	3,317	$70K
80338		<1%	24,631	$67K
80368		<1%	32,376	$67K
80360		<1%	29,387	$59K
L1832	Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	350	$49K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	4,283	$49K
80357		<1%	24,631	$49K
80333		<1%	24,641	$49K
99385		<1%	548	$49K
L0631	Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	188	$48K
98977		<1%	1,269	$48K
64484		<1%	1,124	$44K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	630	$40K
64495		<1%	1,610	$34K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	5,167	$34K
98940		<1%	3,145	$34K
62370		<1%	957	$25K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	3,074	$17K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	4,859	$16K
99457		<1%	795	$16K
L2397	Addition to lower extremity orthosis, suspension sleeve	<1%	354	$14K
97032		<1%	1,810	$13K
L2810	Addition to lower extremity orthosis, knee control, condylar pad	<1%	346	$11K
99454		<1%	295	$11K
64490		<1%	211	$11K
J3490	Unclassified drugs	<1%	11,944	$11K
L1843	Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	78	$10K
97014		<1%	1,438	$9K
20553		<1%	517	$9K
99203	Doctor's office visit, new patient (routine)	<1%	337	$7K
98975		<1%	684	$6K
64491		<1%	209	$6K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	451	$5K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	9,165	$5K
99458		<1%	562	$4K
99422		<1%	224	$4K
L1833	Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf	<1%	14	$3K
64492		<1%	90	$3K
G0438	Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	<1%	154	$2K
97750		<1%	225	$2K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	15,286	$2K
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	83	$2K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	224	$2K
99442		<1%	48	$2K
98970		<1%	371	$2K
97012		<1%	198	$2K
99421		<1%	168	$1K
99453		<1%	159	$1K
98976		<1%	41	$1K
92546		<1%	29	$1K
97010		<1%	1,215	$1K
98971		<1%	121	$1K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	428	$1K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	195	$453.71
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	15	$416.64
92537		<1%	14	$381.96
97535	Self-care/home management training, each 15 minutes	<1%	19	$289.83
99443		<1%	31	$287.32
96120		<1%	89	$144.30
80305		<1%	3,720	$115.52
96103		<1%	121	$28.55
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	537	$0.04
97039		0%	166	$0.00
99024		0%	155	$0.00
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	82	$0.00
99406		0%	105	$0.00
98943		0%	40	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSUNDARARAJAN, VENKATESH (OWNER)